Skip to content
Home / Companies / ROIV ROI
Roivant Sciences Ltd. (ROIV) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest ROIV Insider Trades
About Roivant Sciences Ltd. (ROIV) Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Headquarters LONDON
Employees 721
Listed 2021
Exchange XNAS https://www.roivant.com SEC filings for ROIV on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 31 6,942,239 $240.36M Grant or award 3 1,723 Option exercise 25 4,855,500
ROIV Insider Transactions (Form 4) 85 119 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 3.
Date Insider Transaction Security Shares Price Value Aug 20, 2026 RP Richard Pulik - Officer Tax withholding / forfeiture Common Shares
Recent ROIV Form 8-K Filings 5
Recent ROIV Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 28, 2026 Venker Eric Officer 200,000 $7.15M View on EDGAR Aug 21, 2026 MAYUKH SUKHATME Officer, Director
ROIV Insider Trading - FAQ
What is the latest insider trade for ROIV? Roivant Sciences Ltd. (ROIV) had 20 insider filings in the last 90 days, with the most recent on 2026-08-25. The full record for ROIV runs to 119 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ROIV stock? No insider purchases of ROIV were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling ROIV stock? 31 insider sales of ROIV were filed in the last 90 days, totaling $240.36M.
Where can I see ROIV SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks ROIV Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ROIV insider buys? Create a free InsiderAlpha account and press Watch on this page to add ROIV to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Aug 25, 2026 - Richard Pulik view on EDGAR Aug 25, 2026 - Eric Venker view on EDGAR Aug 22, 2026 - Mayukh Sukhatme view on EDGAR Aug 19, 2026 - Mayukh Sukhatme view on EDGAR Jul 30, 2026 - Eric Venker view on EDGAR Jul 22, 2026 - James C. Momtazee view on EDGAR Jul 22, 2026 - Melissa B, Epperly view on EDGAR Jul 22, 2026 - Ilan Oren view on EDGAR Jul 2, 2026 - Matthew Gline view on EDGAR
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track ROIV insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Aug 21, 2026
EV Eric Venker - Officer Open-market sale $6.99M
Jul 27, 2026
Market cap $25.07B
P/E ratio -
Dividend yield -
Average volume 5.62M
52 week high $37.97
52 week low $11.85
Today's high $37.13
Today's low $34.69
Open $37.01
Volume 8.76M
Previous close $37.58
Shares outstanding 722.32M Market cap
$25.07B
721 employees
ROIV Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 31 sales totaling $240.36M.
Most-Active ROIV Insiders - Last 90 Days 10 Tax withholding / forfeiture 7 188,728
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 20, 2026 EV Eric Venker - Officer Tax withholding / forfeiture Common Shares 13,909 $36.84 $512K
Aug 20, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 17,519 $37.30 $653K
Aug 21, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 144,756 $3.85 $557K
Aug 21, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 144,756 $36.48 $5.28M
Aug 20, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 17,519 $3.85 $67K
Aug 19, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 172,899 $3.85 $666K
Aug 19, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 172,899 $37.17 $6.43M
Aug 19, 2026 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 172,899 $0.00 -
Aug 20, 2026 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 17,519 $0.00 -
Aug 21, 2026 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 144,756 $0.00 -
Aug 14, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 243,177 $3.85 $936K
Aug 14, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 243,177 $36.23 $8.81M
Aug 17, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 284,707 $3.85 $1.10M
Aug 17, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 284,707 $36.25 $10.32M
Aug 18, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 105,141 $3.85 $405K
Aug 18, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 105,141 $36.59 $3.85M
Aug 18, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 31,801 $3.85 $122K
Aug 18, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 31,801 $37.18 $1.18M
Aug 14, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 243,177 $0.00 -
Aug 17, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 284,707 $0.00 -
Aug 18, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 136,942 $0.00 -
Jul 27, 2026 EV Eric Venker - Officer Option exercise Common Shares 200,000 $3.85 $770K
Jul 27, 2026 EV Eric Venker - Officer Open-market sale Common Shares 200,000 $34.95 $6.99M
Jul 27, 2026 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 200,000 $0.00 -
Jul 17, 2026 IO Ilan Oren Grant or award Common Shares 775 $0.00 -
Jun 30, 2026 MG Matthew Gline - Officer Tax withholding / forfeiture Common Shares 76,171 $35.39 $2.70M
Jun 30, 2026 MF Meghan Fitzgerald - Director Option exercise Common Shares 10,000 $8.80 $88K
Jun 30, 2026 MF Meghan Fitzgerald - Director Open-market sale Common Shares 10,000 $34.90 $349K
Jun 30, 2026 MF Meghan Fitzgerald - Director Option exercise Stock Option (Right to Buy) 10,000 $0.00 -
Jun 30, 2026 FT Frank Torti - Officer Tax withholding / forfeiture Common Shares 40,310 $35.39 $1.43M
Jun 30, 2026 MS Mayukh Sukhatme - Officer Tax withholding / forfeiture Common Shares 46,878 $35.39 $1.66M
Jun 29, 2026 ME Melissa B, Epperly - Director Option exercise Stock Option (Right to Buy) 17,750 $0.00 -
Jun 25, 2026 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 500,000 $0.00 -
Jun 26, 2026 MS Mayukh Sukhatme - Officer Option exercise Stock Option (Right to Buy) 500,000 $0.00 -
Jun 25, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 500,000 $3.85 $1.93M
Jun 26, 2026 MS Mayukh Sukhatme - Officer Option exercise Common Shares 500,000 $3.85 $1.93M
Jun 25, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 500,000 $34.13 $17.07M
Jun 26, 2026 MS Mayukh Sukhatme - Officer Open-market sale Common Shares 500,000 $34.08 $17.04M
Jun 24, 2026 EV Eric Venker - Officer Open-market sale Common Shares 46,234 $33.51 $1.55M
Jun 24, 2026 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 200,000 $0.00 -
Jun 24, 2026 EV Eric Venker - Officer Option exercise Common Shares 200,000 $3.85 $770K
Jun 24, 2026 EV Eric Venker - Officer Open-market sale Common Shares 153,766 $33.05 $5.08M
Jun 20, 2026 RP Richard Pulik - Officer Tax withholding / forfeiture Common Shares 2,129 $31.43 $67K
Jun 20, 2026 JH Jennifer Humes - Officer Tax withholding / forfeiture Common Shares 3,582 $31.43 $113K
May 20, 2026 EV Eric Venker - Officer Tax withholding / forfeiture Common Shares 34,483 $32.41 $1.12M
May 22, 2026 EV Eric Venker - Officer Option exercise Common Shares 200,000 $3.85 $770K
May 22, 2026 EV Eric Venker - Officer Open-market sale Common Shares 200,000 $30.27 $6.05M
May 22, 2026 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 200,000 $0.00 -
May 20, 2026 RP Richard Pulik - Officer Tax withholding / forfeiture Common Shares 18,962 $32.41 $615K
Apr 20, 2026 EV Eric Venker - Officer Option exercise Common Shares 200,000 $3.85 $770K
Apr 20, 2026 EV Eric Venker - Officer Open-market sale Common Shares 200,000 $29.59 $5.92M
Apr 20, 2026 EV Eric Venker - Officer Option exercise Stock Option (Right to Buy) 200,000 $0.00 -
Apr 20, 2026 RP Richard Pulik - Officer Grant or award Common Shares 60,644 $0.00 -
Apr 20, 2026 RP Richard Pulik - Officer Grant or award Stock Option (Right to Buy) 84,026 $0.00 -
Apr 20, 2026 JH Jennifer Humes - Officer Grant or award Common Shares 29,173 $0.00 -
Apr 20, 2026 JH Jennifer Humes - Officer Grant or award Stock Option (Right to Buy) 27,157 $0.00 -
Apr 17, 2026 IO Ilan Oren Grant or award Common Shares 896 $0.00 -
Apr 17, 2026 IO Ilan Oren Tax withholding / forfeiture Common Shares 95 $29.83 $3K
Apr 17, 2026 JM James C. Momtazee - Director Tax withholding / forfeiture Common Shares 94 $29.83 $3K
Apr 16, 2026 MG Matthew Gline - Officer Open-market sale Common Shares 289,774 $29.16 $8.45M
Apr 8, 2026 JH Jennifer Humes - Officer Open-market sale Common Shares 13,538 $28.37 $384K
Aug 20, 2026 MAYUKH SUKHATME Officer, Director 17,519 $653K View on EDGAR
$CORT
CORCEPT THERAPEUTICS INC
Richard Pulik - Officer
